Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group

Thumbnail Image

Files

Escobar 2022 Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group.pdf (3.49 MB)

Date

2022-01-31

Document type

journal article

Collections

Investigación
Total downloads15
Total views3
Bibliographic managers

Authors

Escobar, Alejandro, Reyes-López, Felipe E., Acevedo, Monica L., Alonso-Palomares, Luis, Valiente-Echeverria, Fernando, Soto-Rifo, Ricardo, Portillo, Hugo, Gatica, Jimena, Flores, Iván, Nova-Lamperti, Estefania, Barrera-Avalos, Carlos, Bono, Maria Rosa, Vargas, Leonardo, Simon, Valeska, Leiva-Salcedo, Elias, Vial, Cecilia, Hormazabal, Juan, Cortes, Lina Jimena, Valdes, Daniel, Sandino, Ana M., Imarai, Monica, Acuña-Castillo, Claudio

Publisher

FRONTIERS MEDIA SA

URI

https://repositorio.udla.cl/handle/udla/945

DOI

https://doi.org/10.3389/fimmu.2021.766278

Keywords

CoronaVac, SARS-CoV-2, herd immunity, neutralizing antibodies, COVID-19, vaccine, immunological memory

Citation

Frontiers in Immunology, 12, 766278. https://doi.org/10.3389/fimmu.2021.766278

Abstract

CoronaVac vaccine from Sinovac Life Science is currently being used in several countries. In Chile, the effectiveness of preventing hospitalization is higher than 80% with a vaccination schedule. Howe...

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Creative Commons Attribution 4.0 International
Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Usage statistics
01345
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26